Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection

71Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The recombinant vaccinia viruses expressing the surface protein of Neospora caninum tachyzoite, NcSAG1 or NcSRS2, were constructed. The vaccination with these recombinant viruses could protect effectively the parasite invasion in a mouse model system. The vaccine efficacy of NcSRS2 was higher than that of NcSAG1. The present study indicated that a high level of IgG1 Ab production to parasite is important for clearance of parasite at the early stage of infection and that T cell response has a crucial role for protection against the intracellular infection at the late stage of infection. The recombinant vaccinia viruses might be applicable as vaccine against N. caninum infection in a natural host. © 2001 Elsevier Science Ltd.

Cite

CITATION STYLE

APA

Nishikawa, Y., Inoue, N., Xuan, X., Nagasawa, H., Igarashi, I., Fujisaki, K., … Mikami, T. (2001). Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection. Vaccine, 19(11–12), 1381–1390. https://doi.org/10.1016/S0264-410X(00)00389-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free